Podcasts about neurology neurosurgery

Through the telling of stories crafted to inspire love, understanding, and advocacy for wildlife, veterinarian and conservation photographer Rick LeCouteur's journey has evolved beyond clinics and teaching, into the enchanting realm of children's literature, including his upcoming children's book Nasty Names Are Hurtful: An Australian White Ibis in the City [November 12th, 2024]. Through his stories about animals, Rick seeks to cultivate in young readers a sense of curiosity, empathy, and responsibility toward the natural world.   Rick brings a unique perspective, blending expertise in conservation photography, digital art, wildlife expeditions, and a career as a veterinary neurosurgeon to create captivating stories that educate and inspire young readers. In interviews, articles, and expert commentary.  About Dr. Rick LeCouteur Based on a childhood spent immersed in the rustic charm of rural Australia, Rick's love for animals blossomed into a lifelong career as a veterinary educator, conservation photographer, and advocate for animal well-being. Currently, as director of education for a company dedicated to introducing people to the wonders of wildlife in remote locations, Rick shares his love and knowledge of animals with enthusiasts of all ages. Through the telling of stories crafted to inspire love, understanding, and advocacy for wildlife, Rick's journey has evolved beyond clinics and teaching, into the enchanting realm of children's literature. Through his stories about animals, Rick seeks to cultivate in young readers a sense of curiosity, empathy, and responsibility toward the natural world. Moreover, Rick's narratives serve as a clarion call for environmental stewardship in the face of climate challenges. Rick believes that by nurturing young minds with the mystery and fascination of animals, we can sow the seeds of compassion and a deep reverence for the delicate balance of life on our planet. Through his stories and illustrations, Rick hopes to kindle imagination in young hearts and to inspire a new generation of animal lovers and conservationists.   Richard A. LeCouteur, DVSc, PhD, Diplomate ACVIM(Neurology), Diplomate ECVN, FANZCVS (Hon. Causa), MRCVS Professor Emeritus, Neurology & Neurosurgery, University of California, Davis Author/Illustrator Website https://www.ricklecouteur.com Vet-Ex https://www.facebook.com/Veterinary-Expeditions-LLC-491712164350575/ https://www.veterinaryexpeditions.com Linkedin https://www.linkedin.com/in/richard-le-couteur-61294218/ Instagram https://www.instagram.com/ricklecouteur/  

Il cervello di uomini e donne invecchia in modo diverso. A dirlo uno studio pubblicato sul Journal of Neurology Neurosurgery & Psychiatry dei ricercatori dell’Imperial College di Londra che commentiamo a Obiettivo Salute con il prof. Antonio Suppa, Dipartimento di Neuroscienze Umane, Sapienza Università di Roma e IRCCS Neuromed.

Vet Life Reimagined: What do you do when you realize that you are NOT where you want to be in your career, and you are elbow deep? Dr. Samantha Vitale was in the middle of a neurology residency and had to deal with the realization that she needed to change the career identity that she had created in her mind. This is not easy. Dr. Vitale walks through her veterinary journey to now where she is thriving in the veterinary profession. She is connecting the profession with a teleconsulting platform called Stratocyte, which she co-founded. In this episode:- Learn about how you can handle a BIG career pivot- Learn how to leverage tele-consulting to optimize access to care- Learn that when we are connected and working together as a veterinary profession, that's when we can achieve the ultimate access to targeted patient careResources:Stratocyte websiteAbout the guest:Samantha is from Memphis, TN. She obtained her bachelors and DVM degrees from Mississippi State University. She then went on to complete a small animal rotating internship at the University of Georgia and a speciality internship and Neurology/Neurosurgery residency at the University of Illinois. She worked in private practice as a locum neurologist for 2 years before leaving clinical practice to devote her full time to teleconsulting and running Stratocyte. She currently lives in central Illinois with her husband, dog, and 20 chickens. **PSA** Thank you for being a listener! If you listen on the Stitcher platform, this app will be discontinued on August 29th. There are many other great podcast platforms like Podopolo (you can use my referral code megansprinkle), Podbean, Overcast, Spotify, and more. Support the showMore Vet Life Reimagined?

Climate change is real. Awfully real. Hear of the real threats posed by climate change to those with epilepsy and what we can do to help make change and minimise risk. With global lead Prof. Sanjay Sisodiya - Consultant Neurologist at UCL Queen Square Institute of Neurology & Neurosurgery, UK.  ------------------------------------------ More about Sanjay:

Upper Valley Neurology Neurosurgery, with primary offices in Lebanon NH has been recognized as the best performing in Back Surgery & Spinal Fusion by U.S. News & World Report.

In this episode, I interview Dr. Robert Sapolsky, Ph.D., Professor of Biology, Neurology & Neurosurgery at Stanford University. We discuss stress, what defines short-term versus long-term stress, and how stress can be beneficial or detrimental, depending on the context. We also discuss stress mitigation and how our sense of control over stress mitigation techniques, including exercise, determine health outcomes. Dr. Sapolsky explains some of the key effects of the hormone testosterone — how it can amplify pre-existing tendencies for aggression or sexual behavior, but that it does not produce those behaviors per se. He also explains how testosterone impacts our social hierarchies, sense of confidence, and willingness to embrace challenges of different kinds. He also explains how our behaviors and perceptions shape testosterone levels. And we discuss estrogen and the powerful role it plays in brain development, health and longevity. Finally, we discuss free will, what it means to have free will, and if we have any free will, including how knowledge alone might allow us to make better decisions for ourselves and society.    Thank you to our sponsors: ROKA - https://roka.com - use code "huberman" InsideTracker - https://insidetracker.com/huberman  Belcampo - https://belcampo.com/huberman    Our Patreon page: https://www.patreon.com/andrewhuberman    Supplements from Thorne: http://www.thorne.com/u/huberman    Social: Instagram - https://www.instagram.com/hubermanlab  Twitter - https://twitter.com/hubermanlab  Facebook - https://www.facebook.com/hubermanlab   Website - https://hubermanlab.com  Join Newsletter - https://hubermanlab.com/neural-network    Links: Dr. Sapolsky's most recent book, "Behave: The Biology of Humans At Our Best & Worst": https://amzn.to/3yrZ6k7  Support Research in the Huberman Lab at Stanford on Stress, Sleep & Human Performance: https://hubermanlab.stanford.edu/giving    Timestamps: 00:00:00 Introduction: Dr. Robert Sapolsky  00:02:26 Sponsors: Roka, Inside Tracker, Belcampo  00:06:30 Stress: Short & Long-Term, Good & Bad  00:09:11 Valence & Amygdala  00:11:00 Testosterone: Common Myths vs. Actual Truths  00:15:15 Behaviors that Affect Testosterone   00:17:20 Mindsets & Contexts that Affect Testosterone 00:20:28 How Finger Length Ratios Reflect Prenatal Hormone Levels   00:22:30 Aggression: Male-Female, Female-Male, & Female-Female  00:24:05 Testosterone: The Challenge Hypothesis  00:29:20 How Dopamine Impacts Testosterone & Motivation  00:32:32 Estrogen: Improves Brain & Longevity BUT TIMING IS KEY  00:39:40 Are Testosterone & Sperm Counts in Males Really Dropping?  00:42:15 Stress Mitigation & Our Sense of Control  00:51:35 How Best to Buffer Stress  00:57:04 Power of Perception, Choice & Individual Differences  01:00:32 Context-Setting, Prefrontal Cortex & Hierarchy  01:11:20 How Dr. Sapolsky Accomplishes Deep Thinking   01:13:17 Do We Have Free Will?  01:20:50 How to Apply Knowledge & Learning   01:23:44 Robert's New Book: “Determined: The Science of Life Without Free Will”  01:28:27 Reflections, Support of Podcast, & Supporting Stress Research    Please note that The Huberman Lab Podcast is distinct from Dr. Huberman's teaching and research roles at Stanford University School of Medicine. The information provided in this show is not medical advice, nor should it be taken or applied as a replacement for medical advice. The Huberman Lab Podcast, its employees, guests and affiliates assume no liability for the application of the information discussed.

Dr. Zac Pilossoph, a Long Island, NY born, nationally recognized veterinary medical professional, a top graduate of Tufts University Veterinary School of Medicine with post-graduate focused training in E/CC and Neurology/Neurosurgery at two of the most recognized programs in the country, and a young multidimensional serial entrepreneur, has rapidly and collaboratively helped promote a new wave of global evolution and individual empowerment in more ways than one. In addition to developing and launching several novel platforms in the veterinary and mental health fields, he is now quickly joining some of the most reputable leaders in the cannabis education and innovation space. Dr. Pilossoph is determined to synergize with colleagues, allowing evidence-based information to fuel a rapidly expanding industry. As one of the world’s most proactive cannabis-focused experts in his respective industry, Dr. Pilossoph provides tremendous value by delivering non-bias, harm reduction education, via both large-scale speaking engagements and individualized consultations, to the global cannabis pet and vet industry. Further, he is a Certified CBD Professional Educator through the CBD Training Academy and has started a nationally influential multi-tiered cannabis brokerage firm titled Excelsior Honour Associates. Lastly, he acts as a consultant for the CBD product space in order to impart as much quality, control, and consistency across the industry as much as possible.  Ultimately, through candid education, fierce collaboration, and constructive evolution, Dr. Pilossoph is reversing stigmas and advancing the safe and effective consideration of cannabis into society, for all creatures on Earth.Zac's Links:https://cbddoghealth.com/Instagram Accounts: @VetExcelsior // @cbddoghealthFacebook: https://www.facebook.com/Dr.ZacPilossoph/Zac's Recommended Resources:Dr. Sulak Cannabis Education - https://healer.comAngela Ardolino - https://cbddoghealth.com✦   ✦   ✦   ✦Use code "PODCAST" at checkout to save 15% on your Follow Your Heart Oracle Deck. Get yours at torirerick.com/shop/followyourheartoraclePodcast Instagram: @6degreesfromcannabisPodcast Host: Tori Rerick, PharmDTori's Website: torirerick.comTori’s Instagram: @yourguidetoriEpisode edited by Jacqueline FernandezDisclaimers:This podcast offers health, wellness & cannabis information designed for educational and entertainment purposes only. You should not rely on this information as a substitute for, nor does it replace, professional medical advice, diagnosis or treatment. Consult a health-care professional if you have concerns or questions related to your health. 

Chaga mushrooms, a natural way to regrow hair?  Tokushima University (Japan), February 28 2021 Alopecia areata is a condition characterized by hair falling out in patches. Research suggests it is caused by the immune system attacking the hair follicles, causing them to shrink and slow down hair production. Because of this, alopecia is called an autoimmune disorder. According to statistics, alopecia is a common autoimmune disorder that affects about 6.8 million people in the U.S. alone. One in five people who suffer from alopecia has a family member with the same condition. Hair loss, however, can vary from nothing more than a few patches to complete loss of hair on the scalp or the entire body. There are currently no mainstream cures for alopecia, and the reason why the immune system attacks hair follicles is still unknown. But in a recent study, researchers at Tokushima University in Japan reported a natural medicine that can potentially reverse the effects of alopecia. Inonotus obliquus, commonly known as chaga, is a parasitic fungus that grows on birch and other trees. It is traditionally used to treat gastrointestinal diseases as well as to maintain healthy hair in many countries in Asia. The researchers screened chaga mushrooms for useful phytochemicals and found that it contains plenty of potential anti-alopecia agents. They discussed their findings in detail in an article published in the Journal of Natural Medicines. Compounds in chaga mushroom promote proliferation of hair follicles Chaga mushrooms refer to the resting body, or sclerotium, of I. obliquus. In countries like China, Korea, Japan and Russia, these mushrooms are known for their favorable effects on lipid metabolism and cardiac function. Research has also found that they possess antibacterial, anti-inflammatory, antioxidant and anti-tumor properties, and even exhibit antiviral properties against the hepatitis C virus and the human immunodeficiency virus. On the other hand, phytochemical analysis of chaga mushrooms reveal that they are rich in polysaccharides, triterpenes and polyphenols. They also contain two components commonly derived from birch trees, namely, betulin (or betulinol) and betulinic acid. Studies show that betulin can help lower cholesterol levels and increase insulin sensitivityin mice, while betulinic acid can activate signaling pathways that lead to cancer cell death. According to Japanese researchers, chaga mushrooms are used in Mongolia to make shampoo that helps with the maintenance of strong, healthy hair. This prompted them to investigate whether chaga mushrooms can be used for the treatment of alopecia. Bioassay-guided fractionation of chaga mushroom extracts allowed them to identify five lanostane-type triterpenes whose structures they confirmed using spectroscopy. The researchers then conducted proliferation assays using human follicle dermal papilla cells (HFDPCs) and found that four of the five triterpenes can promote the proliferation of HFDPCs. The compounds were identified as lanosterol, inotodiol, lanost-8,24-diene-3B,21-diol and trametenolic acid. The researchers also reported that these lanostane-type triterpenes were more potent than minoxidil, a conventional treatment for male-pattern baldness that’s used to promote hair growth. Based on these findings, the researchers concluded that the lanostane-type triterpenes in chaga mushrooms are potent anti-alopecia agents that can be used to stimulate hair growth naturally.      Association of serum folate, vitamin A and vitamin C levels with greater bone mineral density Tiajin Fifth Central Hospital (China), February 22, 20221 According to news originating from the Tianjin Fifth Central Hospital research stated, “The conclusions on the associations of specific vitamin levels with bone mineral density (BMD) were controversial. Therefore, the aims of this study were to examine the associations of serum vitamins levels with BMD and the modified effect of race/ ethnicity on these associations in the US adults.” The news editors obtained a quote from the research from Tianjin Fifth Central Hospital: “This study was from the third National Health and Nutrition Examination Survey. All participants aged 18 years with complete data were eligible. Serum vitamins A, B9, B12, C, and E levels were assayed using the Quantaphase II Radioassay Kit (Bio-Rad). Dual-energy X-ray absorptiometry was employed to measure BMD, including femur neck and the total hip. There were 6023 participants included in the final analysis. Serum folate, vitamins A and C levels were positively associated with BMD. No significant associations of serum vitamins B12 and E levels with BMD were observed. There were positive associations of serum folate level (b = 0.00027 and 0.00032; and 95% CI: 0.00002-0.00057 and 0.00002-0.00063, respectively), vitamin A level (b = 0.01132 and 0.01115; and 95% CI: 0.00478-0.01787 and 0.00430-0.01799, respectively), and vitamin C level (b = 0.00027 and 0.00029; and 95% CI: 0.00012-0.00042 and 0.00013-0.00045, respectively) with BMD at femur neck and the total hip only in the Not Hispanic participants.” According to the news editors, the research concluded: “Elevated serum folate, vitamins A and C levels were associated with a higher BMD. Furthermore, sex and race/ ethnicity modified the associations of serum vitamins levels with BMD.”     Study shows mother's diet may boost immune systems of premature infants Johns Hopkins University, February 25, 2021 Medical researchers have long understood that a pregnant mother's diet has a profound impact on her developing fetus's immune system and that babies -- especially those born prematurely -- who are fed breast milk have a more robust ability to fight disease, suggesting that even after childbirth, a mother's diet matters. However, the biological mechanisms underlying these connections have remained unclear. Now, in a study published Feb. 15, 2021, in the journal Nature Communications, a Johns Hopkins Medicine research team reports that pregnant mice fed a diet rich in a molecule found abundantly in cruciferous vegetables -- such as broccoli, Brussels sprouts and cauliflower -- gave birth to pups with stronger protection against necrotizing enterocolitis (NEC). NEC is a dangerous inflammatory condition that destroys a newborn's intestinal lining, making it one of the leading causes of mortality in premature infants. The team also found that breast milk from these mothers continued to confer immunity against NEC in their offspring.  Seen in as many as 12% of newborn babies weighing less than 3.5 pounds at birth, NEC is a rapidly progressing gastrointestinal emergency in which normally harmless gut bacteria invade the underdeveloped wall of the premature infant's colon, causing inflammation that can ultimately destroy healthy tissue at the site. If enough cells become necrotic (die) so that a hole is created in the intestinal wall, the bacteria can enter the bloodstream and cause life-threatening sepsis. In earlier mouse studies, researchers at Johns Hopkins Medicine showed that NEC results when the underdeveloped intestinal lining in premature infants produces higher-than-normal amounts of a protein called toll-like receptor 4 (TLR4). TLR4 in full-term babies binds with bacteria in the gut and helps keep the microbes in check. However, in premature infants, TLR4 can act like an immune system switch, with excess amounts of the protein mistakenly directing the body's defense mechanism against disease to attack the intestinal wall instead. "Based on this understanding, we designed our latest study to see if indole-3-carbinole, or I3C for short, a chemical compound common in green leafy vegetables and known to switch off the production of TLR4, could be fed to pregnant mice, get passed to their unborn children and then protect them against NEC after birth," says study senior author David Hackam, M.D., Ph.D., surgeon-in-chief at Johns Hopkins Children's Center and professor of surgery at the Johns Hopkins University School of Medicine. "We also wanted to determine if I3C in breast milk could maintain that protection as the infants grow."  In the first of three experiments, Hackam and his colleagues sought to induce NEC in 7-day old mice, half of which were born from mothers fed I3C derived from broccoli during their pregnancies and half from mothers fed a diet without I3C. They found that those born from mothers given I3C throughout gestation were 50% less likely to develop NEC, even with their immune systems still immature at one week after birth. The second experiment examined whether breast milk with I3C could continue to provide infant mice with protection against NEC. To do this, the researchers used mice genetically bred without the binding site on intestinal cells for I3C known as the aryl hydrocarbon receptor (AHR). When AHR-lacking pups were given breast milk from mice fed a diet containing I3C, they could not process the compound. Therefore, they developed severe NEC 50% more frequently than infant mice that had the I3C receptor.  The researchers say this shows in mice -- and suggests in humans -- that AHR must be activated to protect babies from NEC and that what a mother eats during breastfeeding -- in this case, I3C -- can impact the ability of her milk to bolster an infant's developing immune system.  In confirmatory studies, Hackam and his colleagues looked at the amounts of AHR in human tissue obtained from infants undergoing surgery for severe NEC. They found significantly lower than normal levels of the receptor, suggesting that reduced AHR predisposes infants to the disease. Finally, the researchers searched for a novel drug that could be given to pregnant women to optimize AHR's positive effect and reduce the risk of NEC in the event of premature birth. After screening in pregnant mice a variety of compounds already approved by the U.S. Food and Drug Administration for other clinical uses, the researchers observed that one, which they called A18 (clinically known as lansoprazole, a drug approved for the treatment of gastrointestinal hyperacidity), activates the I3C receptor, limits TLR4 signaling and prevents gut bacteria from infiltrating the intestinal wall.  To show the relevance of what they saw in mice, the researchers tested A18 in the laboratory on human intestinal tissue removed from patients with NEC and found the drug produced similar protective results. "These findings enable us to imagine the possibility of developing a maternal diet that can not only boost an infant's overall growth, but also enhance the immune system of a developing fetus and, in turn, reduce the risk of NEC if the baby is born prematurely," says Hackam.   Plant-based diets improve cardiac function, cognitive health Boston University Medical School, February 25, 2021 What if you could improve your heart health and brain function by changing your diet? Boston University School of Medicine researchers have found that by eating more plant-based food such as berries and green leafy vegetables while limiting consumption of foods high in saturated fat and animal products, you can slow down heart failure (HF) and ultimately lower your risk of cognitive decline and dementia. Heart failure (HF) affects over 6.5 million adults in the U.S. In addition to its detrimental effects on several organ systems, presence of HF is associated with higher risk of cognitive decline and dementia. Similarly, changes in cardiac structure and function (cardiac remodeling) that precede the appearance of HF are associated with poor cognitive function and cerebral health.  The adoption of diets, such as the Mediterranean diet (MIND) and the Dietary Approaches to Stop Hypertension (DASH), which are characterized by high intakes of plant-based foods are among lifestyle recommendations for the prevention of HF. However, whether a dietary pattern that emphasizes foods thought to promote the maintenance of neurocognitive health also mitigates changes in cardiac structure and function (cardiac remodeling) has been unclear until now. The researchers found the MIND diet, which emphasizes consumption of berries and green leafy vegetables while limiting intakes of foods high in saturated fat and animal products, positively benefited the hearts' left ventricular function which is responsible for pumping oxygenated blood throughout the body. The researchers evaluated the dietary and echocardiographic data of 2,512 participants of the Framingham Heart Study (Offspring Cohort), compared their MIND diet score to measures of cardiac structure and function and observed that a dietary pattern that emphasizes foods thought to promote the maintenance of neurocognitive health also mitigates cardiac remodeling. According to the researchers previous studies have highlighted the importance of diet as a modifiable risk factor for cognitive decline and dementia. "Our findings highlight the importance of adherence to the MIND diet for a better cardiovascular health and further reduce the burden of cardiovascular disease in the community," explained corresponding author Vanessa Xanthakis, PhD, assistant professor of medicine and biostatistics at BUSM and an Investigator for the Framingham Heart Study. Although Xanthakis acknowledges that following a healthy diet may not always be easy or fit with today's busy schedules, people should make a concerted effort to adhere to healthy eating to help lower risk of disease and achieve better quality of life.         Fear of memory loss impacts well-being and quality of life Trinity College Dublin, February 23, 2021 Research from the Global Brain Health Institute (GBHI) at Trinity College suggests that experiencing high levels of fear about dementia can have harmful effects on older adults' beliefs about their memory and general well-being. To date, few studies have measured the impact of dementia-related fear on daily functioning, despite its clinical relevance. In this new study, published in the journal Aging and Mental Health, researchers investigated if fear of memory decline predicted increased memory failures and poorer quality of life in older adults. Dr. Francesca Farina, Atlantic Fellow for Equity in Brain Health at GBHI, in collaboration with researchers at the University of Cambridge, University of Maastricht and Northwestern University developed a novel scale—known as the Fear of Memory Loss (FAM) scale—to capture different components of fear related to memory loss. Using the scale, healthy older adults aged 55+ were assessed with respect to the different dimensions of fear. Questions probed specific fears like becoming dependent on others, being treated differently by friends or colleagues, and loss of identity, as well as coping strategies like avoiding social situations for fear of embarrassment. Findings from the study showed that having higher levels of fear about dementia was associated with reporting more memory lapses and a lower quality of life. Notably, these results were independent of performance on memory tests and the level of reported anxiety. That is, fears about dementia had a negative influence on peoples' beliefs regardless of how they performed on an objective lab-based memory test, or how they rated their anxiety levels. Key findings: Heightened fear of memory loss significantly predicted lower quality of life and increased self-reported memory failures, after controlling for objective memory performance and general anxiety. There was no difference in the level of fear expressed between those with and without a family history of dementia. Though surprising, this result is consistent with evidence of widespread fear of dementia among the general population. Over half of respondents (57%) said they worried about losing their memory and feared how people would treat them if this happened. The novel FAM scale highlights the important role played by avoidance behaviors in maintaining fear, along with subjective experiences and cognitions. Findings also have important healthcare implications. Fear of dementia is a psychological process that can be modified using interventions such as psycho-education and psychotherapy. The researchers propose a preliminary fear-avoidance model, where perceived changes in memory result in fear, which over time, creates avoidance and social withdrawal. This combination of fear and avoidance has a negative impact on everyday functioning, which then impairs mood and sense of self. Identifying effective ways to challenge fears about dementia could prove beneficial to individuals and society. On the individual level, reducing fear could lead to improvements in how people view their memory function and quality of life. At the societal level, acknowledging and addressing fears about dementia would help to eliminate stigma associated with the condition. Dr. Francesca Farina, Atlantic Fellow at GBHI, and lead author said: "Almost 80% of the general public are concerned about developing dementia, according to the World Alzheimer Report 2019. Evidence also suggests that these fears increase with age. Given global population aging and the increased visibility of dementia, it is crucial that we find ways to address peoples' fears. Understanding and tackling these fears will serve to promote brain health and well-being, and reduce societal stigma for people living with disease and their carers." Tackling Fear and Stigma Through Art Data from the study inspired "Remembering What I Have Forgotten': a fictional diary written from the perspective of someone experiencing symptoms of dementia. Created by Irish artist Aoibheann Brady, student at the National College of Art and Design, the diary aims to capture the feelings and perspectives of people experiencing memory loss. Through the medium of a diary, "Remembering What I Have Forgotten' offers a realistic insight into the experience of dementia, with entries such as "I feel more withdrawn and am not going out or connecting" and "I am anxious that I will make mistakes." This diary, however, was not written by a person—but by a software application known as a chatbot, which had been trained on anonymous interviews with healthcare professionals and carers of people living with dementia. Aoibheann Brady, creator of "Remembering What I Have Forgotten' said: "With this project, I aimed to create work that is a crossover between art and science. I hope it helps demonstrate, to younger generations and members of the art world, that dementia is something that should be considered more in artistic practices."     Diet of fish and olive oils beneficially modifies membrane properties in striatal rat synaptosomes National Institute of Neurology & Neurosurgery (Mexico), February 25, 2021 According to news reporting originating in Mexico City, Mexico, research stated, “Essential fatty acids (EFAs) and non-essential fatty acids (nEFAs) exert experimental and clinical neuroprotection in neurodegenerative diseases. The main EFAs, eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), nEFAs, and oleic acid (OA) contained in olive and fish oils are inserted into the cell membranes, but the exact mechanism through which they exert neuroprotection is still unknown.” The news reporters obtained a quote from the research from the National Institute of Neurology & Neurosurgery, “In this study, we assessed the fatty acids content and membrane fluidity in striatal rat synaptosomes after fatty acid-rich diets (olive- or a fish-oil diet, 15% w/w). Then, we evaluated the effect of enriching striatum synaptosomes with fatty acids on the oxidative damage produced by the prooxidants ferrous sulfate (FeSO4) or quinolinic acid (QUIN). Lipid profile analysis in striatal synaptosomes showed that EPA content increased in the fish oil group in comparison with control and olive groups. Furthermore, we found that synaptosomes enriched with fatty acids and incubated with QUIN or FeSO4 showed a significant oxidative damage reduction.” According to the news reporters, the research concluded: “Results suggest that EFAs, particularly EPA, improve membrane fluidity and confer antioxidant effect.” This research has been peer-reviewed.     Soy intake is associated with lowering blood pressure in adults: A meta-analysis of randomized double-blind placebo-controlled trials Shiraz University of Medical Sciences (Iran), February 24, 2021 Soy has several beneficial effects on cardiovascular disease (CVD); however, results of clinical trial studies are equivocal. Thus, the present study sought to discern the efficacy of soy intake on blood pressure. Methods The search process was conducted in PubMed, Scopus, Web of Science, and Cochrane Library, to ascertain studies investigating the efficacy of soy intake on blood pressure in adults, published up to June 2020. A random-effects model was applied to pool mean difference and 95% confidence intervals (CIs). Meta-regression analysis was performed to discern potential sources of heterogeneity. Begg’s and Egger’s methods were conducted to assess publication bias. Results Pooled effects from 17 studies revealed a significant improvement in systolic blood pressure (SBP) (-1.64; -3.25 to -0.04 mmHg; I2 = 50.5 %) and diastolic blood pressure (DBP) (-1.21; -2.29 to -0.12 mmHg, I2 = 50.7 %) following soy consumption, in comparison with controls. Subgroup analysis demonstrated a reduction in both SBP and DBP in younger participants with lower baseline blood pressure and intervention durations of

In this episode, we talk with Patricia Limousin about the early days of DBS in the modern era to the current day and about what the future may hold. Building up on episode #4 with Pierre Pollak, we find out how Patricia experienced programming the first bilateral STN-DBS patient, and what has changed over the last 30 years. Professor Limousin has worked at the UCL Institute of Neurology and the National Hospital for Neurology & Neurosurgery since 1997, where she is currently a Professor of Clinical Neurology and Consultant Neurologist. We follow her journey from a PhD with the topic of subthalamic nucleus DBS in Grenoble/Lyon to her move to London, where she helped build one of the leading DBS centers, worldwide.

CBD can not kill your pet Part 2 with Dr. Zac Pilossoph. On today's show, Angela brings in the big guns for this two-part episode with Dr. Zac. They start breaking down the benefits of CBD for your pet as well as myths surrounding the subject. The reality is CBD can not kill your pet! Angela and Dr. Zac tell you why today in part 1 of this 2 part episode of It's A Dog's Life.Dr. Zac Pilossoph is a Long Island, NY born, nationally recognized veterinary medical professional, a top graduate of Tufts University Veterinary School of Medicine with postgraduate focused training in E/CC and Neurology/Neurosurgery at two of the most prestigious programs in the country, and a young multidimensional serial entrepreneur, has rapidly and single-handedly crafted a new wave of diverse global evolution and empowerment. In addition to launching several novel platforms in the extremely relevant mental wellness field, as well as establishing himself as one of the premier global veterinary cannabis educational experts, Zac is simultaneously positively advancing the clinical veterinary industry in many more ways than one. Today we sit down with Dr. Zac to find out why he decided CBD was worth a look and what he has learned since adopting his current methods.

CBD can not kill your pet Part 1 with Dr. Zac Pilossoph. On today's show, Angela brings in the big guns for this two-part episode with Dr. Zac. They start breaking down the benefits of CBD for your pet as well as myths surrounding the subject. The reality is CBD can not kill your pet! Angela and Dr. Zac tell you why today in part 1 of this 2 part episode of It's A Dog's Life.Dr. Zac Pilossoph is a Long Island, NY born, nationally recognized veterinary medical professional, a top graduate of Tufts University Veterinary School of Medicine with postgraduate focused training in E/CC and Neurology/Neurosurgery at two of the most prestigious programs in the country, and a young multidimensional serial entrepreneur, has rapidly and single-handedly crafted a new wave of diverse global evolution and empowerment.

The Cannabis Veterinarian With Dr. Zac Pilissoph. Traditionally vets are not educated in cannabis medicine or diet and nutrition so when a vet goes out of their way to learn about these methods it stands out. Dr. Zac Pilossoph is a nationally recognized medical professional, a top graduate of Tufts University Veterinary School of Medicine with post-graduate focused training in Neurology/Neurosurgery at two of the most prestigious programs in the country. Dr. Zac has rapidly and single-handedly crafted a new wave of global evolution and empowerment in more ways than one. In addition to developing and launching several novel platforms in the veterinary and mental health fields, he is now quickly establishing himself as a pioneer in the medical cannabis field, with the ultimate goal of delivering and applying evidence-based education to a rapidly expanding industry. As one of the only veterinary phytocannabinoid/endocannabinoid physiology experts in the world, Zac has found tremendous value in providing non-bias, harm reduction education to all those associated with the cannabis industry via large-scale CE presentations and individual/corporate business consultations. Today we sit down with Dr. Zac to find out why he decided CBD was worth a look and what he has learned since adopting his current methods.

Zac Pilossoph, Fear-Free Certified DVM and Founder and CEO, YouDoYou LLC. Dr. Zac Pilossoph, a Long Island, NY born, nationally recognized medical professional, a top graduate of Tufts University Veterinary School of Medicine with post-graduate focused training in Neurology/ Neurosurgery at two of the most prestigious programs in the country, and a young multidimensional serial entrepreneur, has rapidly and single-handedly crafted a new wave of global evolution and empowerment in more ways than one. In addition to developing and launching several novel platforms in the veterinary and mental health fields, he is now quickly establishing himself as a pioneer in the medical cannabis field, with the ultimate goal of delivering and applying evidence-based education to a rapidly expanding industry. As one of the only veterinary phytocannabinoid/endocannabinoid physiology experts in the world, Zac has found tremendous value in providing non-bias, harm reduction education to all those associated with the cannabis industry via large-scale CE presentations and individual/corporate business consultations. In addition, he has solidified strong domestic and international collaborations geared towards establishing globalized standardization protocols, prospective research and development, and large-scale use of cannabis biomass subsequent to active molecule extraction. https://www.linkedin.com/in/dr-zac-pilossoph-fear-free-certified-dvm-cavm-certified-cbd-prof-369905b3/  https://www.facebook.com/dr.youdoyou/ https://www.instagram.com/human_excelsior/p/BpLefpeA6rI/  Support the show (https://www.youtube.com/letsbebluntwithmontel )

Zac Pilossoph, Fear-Free Certified DVM Founder and CEO, YouDoYou LLC Dr. Zac Pilossoph, a Long Island, NY born, nationally recognized medical professional, a top graduate of Tufts University Veterinary School of Medicine with post-graduate focused training in E/CC and Neurology/Neurosurgery at two of the most prestigious programs in the country, and a young multidimensional serial entrepreneur, has rapidly and single-handedly crafted a new wave of global evolution and empowerment in more ways than one. In addition to developing and launching several novel platforms in the veterinary and mental health fields, he is now quickly establishing himself as a pioneer in the medical cannabis field, with the ultimate goal of delivering and applying evidence-based education to a rapidly expanding industry. As one of the only veterinary phytocannabinoid/endocannabinoid physiology experts in the world, Zac has found tremendous value in providing non-bias, harm reduction education to all those associated with the cannabis industry via large-scale CE presentations and individual/corporate business consultations. In addition, he has solidified strong domestic and international collaborations geared towards establishing globalized standardization protocols, prospective research and development, and large-scale use of cannabis biomass subsequent to active molecule extraction. Furthermore, he was brought on as the Vice President and CMO of Cansultants, a Florida-based, cannabis cultivation and genomic innovation project that is projected to pioneer the newest wave of cannabis understanding and use on both a micro and macro level. Ultimately, through candid education, responsible application, and promoting constructive evolution via controlled revolution, Zac is ready to unite forces, reverse stigmas, and advance the world of cannabis acceptance across the world.

Zac Pilossoph, Fear-Free Certified DVM Founder and CEO, YouDoYou LLCDr. Zac Pilossoph, a Long Island, NY born, nationally recognized medical professional, a topgraduate of Tufts University Veterinary School of Medicine with post-graduate focused trainingin E/CC and Neurology/Neurosurgery at two of the most prestigious programs in the country, anda young multidimensional serial entrepreneur, has rapidly and single-handedly crafted a newwave of global evolution and empowerment in more ways than one. In addition to developing andlaunching several novel platforms in the veterinary and mental health fields, he is now quicklyestablishing himself as a pioneer in the medical cannabis field, with the ultimate goal ofdelivering and applying evidence-based education to a rapidly expanding industry. As one of theonly veterinary phytocannabinoid/endocannabinoid physiology experts in the world, Zac hasfound tremendous value in providing non-bias, harm reduction education to all those associatedwith the cannabis industry via large-scale CE presentations and individual/corporate businessconsultations. In addition, he has solidified strong domestic and international collaborationsgeared towards establishing globalized standardization protocols, prospective research anddevelopment, and large-scale use of cannabis biomass subsequent to active molecule extraction.Furthermore, he was brought on as the Vice President and CMO of Cansultants, a Florida-based,cannabis cultivation and genomic innovation project that is projected to pioneer the newest waveof cannabis understanding and use on both a micro and macro level. Ultimately, through candideducation, responsible application, and promoting constructive evolution via controlledrevolution, Zac is ready to unite forces, reverse stigmas, and advance the world of cannabisacceptance across the world.

Aired Thursday, 29 March 2018, 1:00 – 3:00 PM ESTSpontaneous Healing Part 2 of 3On this week’s show, we continue our deep dive into the realm of “Spontaneous Healing” as the practice of being open to the unknown. We will inquire about the implications as pertaining to chronic pain – whether physical, emotional or spiritual. We discuss how we can dissolve pain and live from a place of relational wisdom rather than seeking it.CONTRIBUTORS:Glenn Brooks, Host.Dr. Gerry Leisman who is making remarkable leaps in the realm of movement & cognition with the production of MOVEMENTIS at Harvard University. Dr. Leisman is the Director of the Institute for Brain & Rehabilitation Sciences-Israel and Scientific Director of National Institute for Brain and Rehabilitation Sciences-USA. He is concurrently Full Professor of Neuro and Rehabilitation Sciences in the School of Health Sciences of the University of Haifa and Research Fellow in the University’s Research Authority. He is also Professor of Neurology in the Department of Clinical Electrophysiology at the Institute for Neurology & Neurosurgery, University of the Medical Sciences, Facultad ‘Manuel Fajardo’ in Havana, Cuba.Dr. C. Norm Shealy is one of the world’s leading experts in pain and depression management, He was the first physician to specialize in the resolution of chronic pain. He opened his first pain management clinic in La Crosse, Wisconsin and developed a long series of successes in treating patients who had been otherwise untreatable. During this period, he developed a device called the dorsal column stimulator, which uses small electrical currents to adjust the electromagnetic fields within the spinal column. The stimulator was so successful in treating previously untreatable chronic back pain that it has become a favored treatment for pain by physicians world-wide.Kimchi Moyer, Resopath. Resopathy is a health modality, rooted in over 25 years of meticulous research by Kimchi Moyer, L.Ac., using both resonance and biofeedback technologies to decode the language of the body. Known as an expert “detective” in the health field, Kimchi has developed a unique protocol allowing her to identify the root causes of various health issues, and to pinpoint the tools that will best aid the body in restoring itself back to optimum health.Kai Cole – Tribe Architect & Executive Producer. Tribe Architecture represents the cross-section of cultural engineering and marketing/PR. Kai was traditionally trained as an Architect and later translated her skills to become a Celebrity Publicist at a prominent firm in NYC. Currently, Kai has been laser-focused on building sustainable social constructs to spread the message of conscious healing across the globe.

Walker Foland is an emergency physician practicing in Michigan and in this episode breaks down why pseudoseizures, now termed PNES (Psychogenic Nonepileptic Seizures), are a real disease.   Sign up for the ERcast mailing list Are patients with PNES ‘faking it’? PNES is a conversion disorder: an unconscious manifestation of psychological trauma. Walker treats PNES patients with haloperidol or olanzapine with the thinking that this is psychological, not true epilepsy PNES is not ‘faking it’ or lying   Challenges Patients with PNES may also have true epileptic seizures Diagnosing PNES, or separating it from epilepsy, may take video EEG monitoring, a neurologist, and sometimes prolonged periods of time to figure things out   How to tell the difference between an grand mal epileptic seizure vs PNES vs faking it? PNES Seizures related to a specific stimulus (sound foods, body movement) Frequency and amplitude of concussions: same frequency through the seizure with varying amplitude. Maintenance of consciousness and may have some of the below may guard the face with passive hand drop resist eyelid opening visual fixation on a mirror Whit Fisher, Dr Procedurettes, squirts water in the face of patients where there is thought of PNES.  If they grimace, probably not an epileptic seizure. Faking Seizures Talking Purposeful movement Avoids injury May use convulsions as a way of harming staff Intermittently awake and vocal during the episode Epileptic seizure Convulsive frequency decreases, amplitude increases as seizure progresses No response to pain Allow passive eye opening   A 2010 article from the Journal of Neurology Neurosurgery and Psychiatry broke down the evidence of what other elements can help distinguish PNES from epileptic seizures. Duration over 2 minutes suggests PNES, but we’ve all seen epileptic seizures last for a long time, status, and some PNES can be super short Happens in sleep. Evidence suggests that if the event happens in sleep, that is probably episode. PNES episodes happen when awake Fluctuating course such as a pause in the rhytmic movement, epileptic seizures usually don’t pause and then restart, a pause favors PNES Flailing. You’d think the flailing patient has PNES for sure because epilepsy doesn’t flail, but it does! Flailing is much more common in PNES, but not so much so that it’s a clear distinguishing factor Urinary incontinence, more common in epilepsy, but does happen in PNES. Post-ictal recovery period. Surely, this is the sine qua non of epilepsy.  It is way way more common following generalized epileptic seizures but happens in around 15% of PNES. The sterterous breathing (noisy, labored) that we see after generalized tonic clonic epileptic seizures suggests epilepsy and is not a characteristic of PNES   Walker’s take home points PNES patients aren’t ‘faking it’ This is a real disorder, it's just not epilepsy References Chen, David K., and W. Curt LaFrance Jr. "Diagnosis and treatment of nonepileptic seizures." CONTINUUM: Lifelong Learning in Neurology 22.1, Epilepsy (2016): 116-131. PMID:26844733 Avbersek, Andreja, and Sanjay Sisodiya. "Does the primary literature provide support for clinical signs used to distinguish psychogenic nonepileptic seizures from epileptic seizures?." Journal of Neurology, Neurosurgery & Psychiatry 81.7 (2010): 719-725.Full Text PMID:20581136  Shen, Wayne, Elizabeth S. Bowman, and Omkar N. Markand. "Presenting the diagnosis of pseudoseizure." Neurology 40.5 (1990): 756-756. Full Text PMID:2330101

In this podcast we bring you a research updatewith Dr. Simon Platt of the University of Georgia College of Veterinary Medicine. Dr. Platt received his veterinary degree from the University of Edinburgh, Scotland in 1992, he completed a residency in neurology and neurosurgery in 1998 at the University of Florida, and afterward spent two years as an assistant professor of Neurology at the University of Georgia. In 2000, Dr. Platt returned to the UK where he was Head of the Neurology/Neurosurgery service at the Animal Health Trust until 2006. Since then he has been an associate professor and then professor in the Department of Small Animal Medicine and Surgery at the University of Georgia. Dr. Platt discusses his CHF-funded research on Syringomyelia, or SM for short, entitled “Syringomyelia in the Brussels Griffon: magnetic resonance imaging finding, clinicopathology and prevalence.” This podcast was made possible thanks to the generous support of the Kenneth A. Scott Charitable Trust, a KeyBank Trust.

1) Frontotemporal dementia and 2) Topic of the month: Featured speakers from the AAN Meeting. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns interviews Dr. Keith Jospehs about his paper on frontotemproal dementia with motor neuron disease. In the next segment, Dr. Sarah Song is reading our e-Pearl of the week about SMART syndrome. In the next part of the podcast Dr. Alberto Espay interviews Dr. Dennis Dickson about receiving the Potamkin Prize for Research in Pick's Alzheimer's and related diseases at the AAN Meeting. In concluding, there is a brief statement where to find other up-to date patient information and current Patient Page. The participants had nothing to disclose except Drs. Burns, Josephs, Song, Espay and Dickson.Dr. Burns serves as Podcast Editor for Neurology®; performs EMG studies in his neuromuscular practice (30% effort); and has received research support from the Myasthenia Gravis Foundation of America and Knopp Neurosciences Inc..Dr. Josephs receives research support from the NIH (NIDCD, NIA) and the Dana Foundation.Dr. Song served on the editorial team for the Neurology® Resident and Fellow Section. Dr. Espay serves on scientific advisory boards for Boehringer Ingelheim and Solvay Pharmaceuticals, Inc.; serves on the editorial advisory board for The European Neurological Journal; has received speaker honoraria from UCB/SCHWARZ PHARMA, Medtronic, Inc., and Novartis; has received honoraria from Novartis, the American Academy of Neurology, and the Movement Disorders Society; has served on speakers' bureaus for UCB/SCHWARZ PHARMA and Novartis; receives/has received research support from Medtronic, Inc., Allergan, Inc., CleveMed, the KL2 Research Scholars mentored career development award, and NIH Institutional Clinical and Translational Science Award (RR026315-02), Dean Scholar's Award - University of Cincinnati, Davis Phinney Foundation, and the Michael J Fox Foundation. Dr. Dickson serves on the editorial boards of the American Journal of Pathology, Journal of Neuropathology and Experimental Neurology, Brain Pathology, Neurobiology of Aging, Journal of Neurology Neurosurgery and Psychiatry, Annals of Neurology, and Neuropathology; and receives research support from the NIH and Cure PSP/Society for PSP.

1) Depression in Parkinson disease and 2) Topic of the month: Aphasia. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Russ Swerdlow interviews Dr. Massimo Filippi about his paper on depression in Parkinson disease. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about five clues to the diagnosis of inclusion body myositis...and...amphiphysin antibody-associated stiff-person syndrome. In the next part of the podcast Dr. Alberto Espay interviews Dr. Keith Josephs about post-stroke aphasias for our Lesson of the Week. Over the next subsequent three weeks, we will highlight primary progressive aphasias. The participants had nothing to disclose except Drs. Filippi, Overman, Espay and Josephs. Dr. Filippi serves on scientific advisory boards for Teva Pharmaceutical Industries Ltd. and Genmab A/S; has received funding for travel from Bayer Schering Pharma, Biogen-Dompe AG, Genmab A/S, Merck-Serono, and Teva Pharmaceutical Industries Ltd.; serves on editorial boards of the American Journal of Neuroradiology, BMC Musculoskeletal Disorders, Clinical Neurology and Neurosurgery, Erciyes Medical Journal, Journal of Neuroimaging, Journal of Neurology Neurosurgery and Psychiatry, Journal of Neurovirology, Magnetic Resonance Imaging, Multiple Sclerosis, and Neurological Sciences; serves as a consultant to Bayer Schering Pharma, Biogen-Dompe AG, Genmab A/S, Merck-Serono, Pepgen Corporation, and Teva Pharmaceutical Industries Ltd.; serves on speakers' bureaus for Bayer Schering Pharma, Biogen-Dompe AG, Genmab A/S, Merck-Serono, and Teva Pharmaceutical Industries Ltd.; and receives research support from Bayer Schering Pharma, Biogen-Dompe AG, Genmab A/S, Merck-Serono, Teva Pharmaceutical Industries Ltd., Fondazione Italiana Sclerosi Multipla, and Fondazione Mariani. Dr. Overman serves as Deputy Editor on the Neurology® Resident and Fellow Section editorial team and the Neurology® Podcast Committee. Dr. Espay received has personal compensation as a consultant for Boehringer Ingelheim; grant support from Codman; Medtronic, Inc; Allergan, Inc.; and CleveMed, and honoraria from UCB-SCHWARZ PHARMA AG; Medtronic, Inc. and Novartis. Dr. Josephs is funded by R01- DC010367 (PI), the Dana Foundation (PI), and the Morris K. Udall PD Research Center of Excellence NIH/NINDS P50 NS40256 (Co-I).

This Podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Mark Keegan interview Dr. Massimo Filippi about his paper on oral vs. intravenous methyprednisolone in MS. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about pseudo-myasthenic ptosis. The next part of the podcast is Dr. Alberto Espay interviews Dr. Josep Dalmau for our Lesson of the week toolbox about NMDAR encephalitis. The participants had nothing to disclosure except Drs. Keegan, Filippi, Espay and Dalmau. Dr. Keegan serves as Section Co-Editor for Neurology and the Neurology Podcast Panel.Dr. Filippi serves on scientific advisory boards for Teva Pharmaceutical Industries Ltd. and Genmab A/S; has received funding for travel from Bayer Schering Pharma, Biogen-Dompè AG, Genmab A/S, Merck Serono, and Teva Pharmaceutical Industries Ltd.; serves on editorial boards of the American Journal of Neuroradiology, BMC Musculoskeletal Disorders, Clinical Neurology and Neurosurgery, Erciyes Medical Journal, Journal of Neuroimaging, Journal of Neurology Neurosurgery and Psychiatry, Journal of Neurovirology, Magnetic Resonance Imaging, Multiple Sclerosis, and Neurological Sciences ; serves as a consultant to Bayer Schering Pharma, Biogen-Dompè AG, Genmab A/S, Merck Serono, Pepgen Corporation, and Teva Pharmaceutical Industries Ltd.; serves on speakers' bureaus for Bayer Schering Pharma, Biogen-Dompè AG, Genmab A/S, Merck Serono, and Teva Pharmaceutical Industries Ltd.; and receives research support from Bayer Schering Pharma, Biogen-Dompè AG, Genmab A/S, Merck Serono, Teva Pharmaceutical Industries Ltd., Fondazione Italiana Sclerosi Multipla, and Fondazione Mariani. Dr. Espay has received personal compensation as a consultant for Boehringer Ingelheim; grant support from Codman; Medtronic, Inc; Allergan, Inc.; and CleveMed, and honoraria from UCB-SCHWARZ PHARMA AG; Medtronic, Inc. and Novartis.Dr. Dalmau has received honoraria for lectures not funded by industry; receives research support from EUROIMMUN and the NIH/NCI [RO1CA107192 (PI) and RO1CA89054-06A2 (PI)]; has received license fee payments from EUROIMMUN for an NMDA receptor autoantibody test (patent pending PCT/US07/18092, filed: August 15, 2007); and has received royalty payments and may accrue revenue for US Patent 6,387,639;, issued: May 14th, 2002: Patent for Ma2 autoantibody test.

CBD can not kill your pet Part 1 with Dr. Zac Pilossoph. On today's show, Angela brings in the big guns for this two-part episode with Dr. Zac. They start breaking down the benefits of CBD for your pet as well as myths surrounding the subject. The reality is CBD can not kill your pet! Angela and Dr. Zac tell you why today in part 1 of this 2 part episode of It's A Dog's Life. Dr. Zac Pilossoph is a Long Island, NY born, nationally recognized veterinary medical professional, a top graduate of Tufts University Veterinary School of Medicine with postgraduate focused training in E/CC and Neurology/Neurosurgery at two of the most prestigious programs in the country, and a young multidimensional serial entrepreneur has rapidly and single-handedly crafted a new wave of diverse global evolution and empowerment.